Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma—Exploration for Achieving Optimal 10-Year Therapeutic Ratio-Reference-Cited by-同舟云学术

Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma—Exploration for Achieving Optimal 10-Year Therapeutic Ratio

Published:2018-08 Issue:5 Volume:101 Page:1078-1086
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Ng Wai-Tong,Tung Stewart Y.,Lee Victor,Ngan Roger K.C.,Choi Horace C.W.,Chan Lucy L.K.,Leung To-Wai,Siu Lillian L.,Lu Tai-Xiang,Tan Terence,Tan Eng-Huat,Sze Henry C.K.,Ng Alice W.Y.,Yiu Harry H.Y.,O'Sullivan Brian,Chappell Rick,Lee Anne W.M.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference15 articles.

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

2. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group;Lee;J Clin Oncol,2005

3. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma;Lee;Int J Radiat Oncol Biol Phys,2006

4. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety;Wee;J Clin Oncol,2005

5. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China;Chen;Int J Radiat Oncol Biol Phys,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study;Oral Oncology;2024-09

2. Determining the optimal timing of adjuvant chemotherapy initiation after concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma;ESMO Open;2024-09

3. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial;The Lancet;2024-06

4. Cross-site prognosis prediction for nasopharyngeal carcinoma from incomplete multi-modal data;Medical Image Analysis;2024-04

5. Prognostic significance of the novel nutrition-inflammation marker of lymphocyte–C-reactive protein ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy;Frontiers in Nutrition;2023-07-20